Express News | Arrowhead Pharmaceuticals Presented Preclinical Data On ARO-ALK7 At Keystone Symposia on Obesity and Adipose Tissue

BenzingaFeb 25 07:33 ET

Arrowhead Pharmaceuticals (ARWR): Among the Most Oversold Healthcare Stocks to Buy Now

Yahoo FinanceFeb 20 12:15 ET

Loss-making Arrowhead Pharmaceuticals (NASDAQ:ARWR) Has Seen Earnings and Shareholder Returns Follow the Same Downward Trajectory Over Past -53%

Simply Wall StFeb 19 14:38 ET

10 Health Care Stocks With Whale Alerts In Today's Session

BenzingaFeb 14 12:35 ET

B.Riley Financial Maintains Arrowhead Pharmaceuticals(ARWR.US) With Buy Rating, Cuts Target Price to $38

Moomoo NewsFeb 14 08:34 ET · Ratings

H.C. Wainwright Maintains Arrowhead Pharmaceuticals(ARWR.US) With Buy Rating, Maintains Target Price $80

Moomoo NewsFeb 12 12:31 ET · Ratings